These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 12019167)

  • 21. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
    Kloetzel PM; Soza A; Stohwasser R
    Biol Chem; 1999 Mar; 380(3):293-7. PubMed ID: 10223331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
    Rechsteiner M; Realini C; Ustrell V
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the proteasome activator PA28 in MHC class I antigen processing.
    Sijts A; Sun Y; Janek K; Kral S; Paschen A; Schadendorf D; Kloetzel PM
    Mol Immunol; 2002 Oct; 39(3-4):165-9. PubMed ID: 12200048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
    Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
    J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin-proteasome system plays essential roles in presenting an 8-mer CTL epitope expressed in APC to corresponding CD8+ T cells.
    Duan X; Hisaeda H; Shen J; Tu L; Imai T; Chou B; Murata S; Chiba T; Tanaka K; Fehling HJ; Koga T; Sueishi K; Himeno K
    Int Immunol; 2006 May; 18(5):679-87. PubMed ID: 16569681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes.
    Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T
    Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
    Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
    Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.
    Benham AM; Neefjes JJ
    J Immunol; 1997 Dec; 159(12):5896-904. PubMed ID: 9550386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.
    Murata S; Udono H; Tanahashi N; Hamada N; Watanabe K; Adachi K; Yamano T; Yui K; Kobayashi N; Kasahara M; Tanaka K; Chiba T
    EMBO J; 2001 Nov; 20(21):5898-907. PubMed ID: 11689430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
    Asemissen AM; Keilholz U; Tenzer S; Müller M; Walter S; Stevanovic S; Schild H; Letsch A; Thiel E; Rammensee HG; Scheibenbogen C
    Clin Cancer Res; 2006 Dec; 12(24):7476-82. PubMed ID: 17189421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
    Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
    J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K; Sasada T; Takedatsu H; Shomura H; Koga M; Maeda Y; Yao A; Hirai T; Takabayashi A; Shichijo S; Itoh K
    Clin Cancer Res; 2004 Oct; 10(19):6695-702. PubMed ID: 15475460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.
    Godefroy E; Moreau-Aubry A; Diez E; Dreno B; Jotereau F; Guilloux Y
    J Exp Med; 2005 Jul; 202(1):61-72. PubMed ID: 15998788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
    Ayyoub M; Rimoldi D; Guillaume P; Romero P; Cerottini JC; Valmori D; Speiser D
    Cancer Res; 2003 Sep; 63(17):5601-6. PubMed ID: 14500401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region.
    Shimbara N; Nakajima H; Tanahashi N; Ogawa K; Niwa S; Uenaka A; Nakayama E; Tanaka K
    Genes Cells; 1997 Dec; 2(12):785-800. PubMed ID: 9544705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.